Learn drug discovery through this intuitive virtual screening workflow! We are keen for your feedback! #Biotech #Chiral

ビジュアル化を改善しました。 3Dポケット構造を、別タブを開かずにインターフェース上で表示できるようになりました。 いつもフィードバックありがとうございます！ ブループリントはこちら： https://t.co/FhH06I8PGN

インシリコ創薬のコミュニティを立ち上げます！ アップデートをお楽しみに！

🧬 Coming Soon at Chiral: Metabolomics Blueprint Happy New Year from Chiral! We’re preparing a new metabolomics in-silico blueprint, designed to connect molecular-level data with disease-relevant biological signals in a genetics-driven context. More to share soon.

その分子は、どこに結合するのか？ その答え、今すぐ・無料で確かめられます。 Pocketeerを使い、PDB IDを1つ入れるだけで、結合ポケットの検出・ランキング・定量化・可視化ができます 🔗 ブループリント https://t.co/FhH06I8PGN 📝 ドキュメント https://t.co/7LXjFPYkaN #創薬

Pocket Detection & Visualization workflow built on Pocketeer by Charlie Harris is now available on Chiral. https://t.co/FhH06I8PGN Try it out and find new pockets! @charlieharris01

New open position! Passionate about ML for science? We’re welcoming researchers, engineers, and students interested in pushing the boundaries of computational discovery. Appreciate it you could spread the words! DM us or apply from below https://t.co/IrhFjtJe3J #drugdiscovery

After launching our virtual screening workflow, several of you shared feedback on how to improve the docking process through better pocket identification. So a workflow dedicated to pocket detection is on the way! #Biotech

🚀 Thank you, Chiralists! Our platform is now at capacity — huge thanks to everyone who signed up and tried it out. 🙏 We’re already preparing new workflows and will reopen access soon. Stay tuned! ✨ #drugdiscovery #Chiral

Thrilled to announce Boltz-1, the first open-source and commercially available model to achieve AlphaFold3-level accuracy on biomolecular structure prediction! An exciting collaboration with @jeremyWohlwend, @pas_saro and an amazing team at MIT and Genesis Therapeutics. A thread!

Thrilled to share our first collaborator-developed, non-code drug discovery workflow on Chiral — built with Chiralist Diego Lima. A fully browser-based virtual screening workflow that helps researchers go from millions of compounds → a meaningful, testable set — with no

A new non-code virtual screening workflow is coming to Chiral. Co-developed with a collaborating scientist, it brings ligand exploration and structure-based screening into one intuitive flow—helping researchers move from idea to insight faster. Stay tuned. #DrugDiscovery

📢We opened a few limited November slots after our small October pilot Chiral = Reproducible, no-code workflow with auto-tuning, and almost zero setup—so you can focus on discovery, not configuration. https://t.co/BY5E7mzhfm Want to join? Sign up at the link above.

【完全版】In silico創薬実践書 〜おうち創薬で論文を書こう〜 https://t.co/qTacgBwQ2f が気づいたらZennでの売り上げが100冊いきました！ 結構大変だったReviseの実験も今年中には追加したいと思います！

Our project with UTokyo, OMU, and TMU will build a cloud-based CFD training platform for the next generation of aerospace engineers. More here: https://t.co/AhG1z0FfcH #Aerospace #CFD #MEXT #Chiral #Chiralist